Alfuzosin HCL ER 10 MG tablet 90S
Ended Awarded Last action
- Contract number
- SPE2DR26FU623
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $17,408
Award facts
- Contract value 100% obligated
- $17,408.36 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $17,408.36 to AmerisourceBergen Drug Corp for the supply of Alfuzosin HCL ER 10 mg tablets (90-count) with a firm fixed price structure. The order, issued on December 10, 2025, with an ultimate completion date of December 11, 2025, represents a non-competitive, non-set-aside delivery against AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. This child delivery order leverages the company's $999.99 billion prime pharmaceutical supply vehicle (SPE2DX), which extends through December 2026 and serves as a comprehensive global pharmaceutical support mechanism for military healthcare programs worldwide.
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement, with particular emphasis on supporting Defense Health Agency and military healthcare systems. The company maintains an extensive portfolio of pharmaceutical products and medical supplies through its DLA contracts, including specialty medications, vaccines, generic and brand-name drugs, and medical devices across multiple therapeutic domains. The performance location for this delivery order is the company's Conshohocken corporate office, continuing AmerisourceBergen's established role as a primary pharmaceutical supplier to the federal government's defense medical supply chain.
Quick answers
Who was awarded contract SPE2DR26FU623?
SPE2DR26FU623 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 10, 2025.
How much is contract SPE2DR26FU623 worth?
The government has obligated $17,408 on SPE2DR26FU623.
Is contract SPE2DR26FU623 an order under another contract?
Yes. SPE2DR26FU623 is a delivery order under SPE2DR25D1053, an indefinite delivery contract.
Was contract SPE2DR26FU623 competed?
The extent of competition for SPE2DR26FU623 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award